Pompe RS - Search Results

1

Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study.

Bandini M, Pompe RS, Marchioni M, Zaffuto E, Gandaglia G, Fossati N, Cindolo L, Montorsi F, Briganti A, Saad F, Karakiewicz PI. Bandini M, et al. Among authors: pompe rs. Int Urol Nephrol. 2018 Jan;50(1):71-78. doi: 10.1007/s11255-017-1744-2. Epub 2017 Nov 11. Int Urol Nephrol. 2018. PMID: 29129028

2

Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis.

Zaffuto E, Pompe R, Zanaty M, Bondarenko HD, Leyh-Bannurah SR, Moschini M, Dell'Oglio P, Gandaglia G, Fossati N, Stabile A, Zorn KC, Montorsi F, Briganti A, Karakiewicz PI. Zaffuto E, et al. Clin Genitourin Cancer. 2017 Oct;15(5):e793-e800. doi: 10.1016/j.clgc.2017.04.006. Epub 2017 Apr 13. Clin Genitourin Cancer. 2017. PMID: 28506524

3

Population-Based Validation of the 2014 ISUP Gleason Grade Groups in Patients Treated With Radical Prostatectomy, Brachytherapy, External Beam Radiation, or no Local Treatment.

Pompe RS, Davis-Bondarenko H, Zaffuto E, Tian Z, Shariat SF, Leyh-Bannurah SR, Schiffmann J, Saad F, Huland H, Graefen M, Tilki D, Karakiewicz PI. Pompe RS, et al. Prostate. 2017 May;77(6):686-693. doi: 10.1002/pros.23316. Epub 2017 Feb 3. Prostate. 2017. PMID: 28156003

4

Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.

Pompe RS, Karakiewicz PI, Tian Z, Mandel P, Steuber T, Schlomm T, Salomon G, Graefen M, Huland H, Tilki D. Pompe RS, et al. J Urol. 2017 Aug;198(2):354-361. doi: 10.1016/j.juro.2017.02.070. Epub 2017 Feb 16. J Urol. 2017. PMID: 28216329

5

Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T_1-2 N₀ M₀ renal cell carcinoma.

Marchioni M, Martel T, Bandini M, Pompe RS, Tian Z, Kapoor A, Cindolo L, Autorino R, Briganti A, Shariat SF, Schips L, Karakiewicz PI. Marchioni M, et al. Among authors: pompe rs. World J Urol. 2017 Dec;35(12):1899-1905. doi: 10.1007/s00345-017-2082-9. Epub 2017 Aug 28. World J Urol. 2017. PMID: 28849260

6

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era.

Marchioni M, Bandini M, Pompe RS, Tian Z, Martel T, Kapoor A, Cindolo L, Berardinelli F, Briganti A, Shariat SF, Schips L, Karakiewicz PI. Marchioni M, et al. Among authors: pompe rs. Int Urol Nephrol. 2017 Dec;49(12):2143-2149. doi: 10.1007/s11255-017-1703-y. Epub 2017 Sep 20. Int Urol Nephrol. 2017. PMID: 28932952

7

The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT_2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy.

Marchioni M, Bandini M, Pompe RS, Martel T, Tian Z, Shariat SF, Kapoor A, Cindolo L, Briganti A, Schips L, Capitanio U, Karakiewicz PI. Marchioni M, et al. Among authors: pompe rs. BJU Int. 2018 Mar;121(3):383-392. doi: 10.1111/bju.14024. Epub 2017 Oct 12. BJU Int. 2018. PMID: 28940649

8

Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy.

Bandini M, Smith A, Zaffuto E, Pompe RS, Marchioni M, Capitanio U, Chun FK, Kapoor AB, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Bandini M, et al. Among authors: pompe rs. World J Urol. 2018 Jan;36(1):51-57. doi: 10.1007/s00345-017-2093-6. Epub 2017 Oct 11. World J Urol. 2018. PMID: 29022072

9

Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis.

Bandini M, Pompe RS, Marchioni M, Tian Z, Gandaglia G, Fossati N, Tilki D, Graefen M, Montorsi F, Shariat SF, Briganti A, Saad F, Karakiewicz PI. Bandini M, et al. Among authors: pompe rs. World J Urol. 2018 Jan;36(1):7-13. doi: 10.1007/s00345-017-2102-9. Epub 2017 Oct 23. World J Urol. 2018. PMID: 29063268

10

Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions.

Gandaglia G, Tilki D, Zaffuto E, Fossati N, Pompe RS, Dell'Oglio P, Graefen M, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: pompe rs. Eur Urol Focus. 2019 Jul;5(4):545-549. doi: 10.1016/j.euf.2017.10.013. Epub 2017 Nov 17. Eur Urol Focus. 2019. PMID: 29153885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters